Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/JNJ stock hub

FRA/JNJ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/JNJis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

452.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/JNJ

In the news

Latest news · FRA/JNJ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6

P25 n/aP50 n/aP75 n/a

Trailing P/E24.8

P25 n/aP50 n/aP75 n/a

ROE26.4

P25 n/aP50 n/aP75 n/a

ROIC19.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/JNJ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	138,200
Employees Change	100%
Employees Change Percent	0.07
Enterprise value	EUR 480.6B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 452.6B
Price	EUR 190
Price currency	EUR
Rev Per Employee	605,225.88x
Sic	2834
Symbol	fra/JNJ
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.03%
EV Earnings	26.32x
EV/EBIT	21.27x
EV/EBITDA	16.39x
EV/FCF	31.14x
EV/Sales	5.87x
FCF yield	3.41%
Forward P/E	18.56x
P/B ratio	6.42x
P/E ratio	24.78x
P/S ratio	5.41x
PE Ratio10 Y	45.82x
PE Ratio3 Y	18.63x
PE Ratio5 Y	21.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.59%
EBITDA Margin	35.62%
FCF margin	18.46%
Gross margin	68.04%
Gross Profit	EUR 56.9B
Gross Profit Growth	6.69%
Gross Profit Growth Q	9.85%
Gross Profit Growth3 Y	6.7%
Gross Profit Growth5 Y	3.28%
Net Income	EUR 18.3B
Net Income Growth	-3.53%
Net Income Growth Q	-52.41%
Net Income Growth3 Y	18.25%
Net Income Growth5 Y	6.84%
Pretax Margin	25.88%
Profit Margin	21.83%
Profit Per Employee	EUR 132,147
ROA	8.42
Roa5y	8.04
ROCE	18.57
ROE	26.42
Roe5y	24.21
ROIC	19.95
Roic5y	23.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.81%
Cagr15y	13.27%
Cagr1y	40.69%
Cagr20y	10.53%
Cagr3y	12.3%
Cagr5y	9.59%
Div CAGR10	5.13%
Div CAGR3	1.06%
Div CAGR5	5.3%
EPS Growth	-3.89
EPS Growth Q	-52.86
EPS Growth3 Y	21.64
EPS Growth5 Y	8.81
FCF Growth	-12.7%
FCF Growth Q	-56.64%
FCF Growth3 Y	3.14%
FCF Growth5 Y	-3.13%
OCF Growth	-7.72%
OCF Growth Q	-39.77%
OCF Growth10 Y	1.93%
OCF Growth3 Y	3.76%
OCF Growth5 Y	-1.17%
Revenue Growth	7.87x
Revenue Growth Q	9.91x
Revenue Growth3 Y	7.55x
Revenue Growth5 Y	2.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.49
Assets	EUR 174.4B
Cash	EUR 19.1B
Current Assets	EUR 50.2B
Current Liabilities	EUR 48.9B
Debt	EUR 47.7B
Debt EBITDA	EUR 1.59
Debt Equity	EUR 0.68
Debt FCF	EUR 3.09
Equity	EUR 70.5B
Interest Coverage	25.59
Liabilities	EUR 103.9B
Long Term Assets	EUR 124.2B
Long Term Liabilities	EUR 55B
Net Cash	EUR -28.6B
Net Cash By Market Cap	EUR -6.32
Net Debt EBITDA	EUR 0.96
Net Debt Equity	EUR 0.41
Net Debt FCF	EUR 1.85
Tangible Book Value	EUR -14.3B
Tangible Book Value Per Share	EUR -5.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Inventory Turnover	2.26
Net Working Capital	EUR -2.7B
Quick ratio	0.69
Working Capital	EUR 1.3B
Working Capital Turnover	EUR 10.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.29%
Dividend Growth	-2.86%
Dividend Growth Years	14%
Dividend per share	EUR 4.49
Dividend Years	29
Dividend Yield	2.36%
Ex Div Date	2026-02-24
Last Dividend	EUR 1.1
Payout Frequency	Quarterly
Payout Ratio	59.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	154.99%
1Y total return	40.65%
200-day SMA	177.4
3Y total return	41.65%
50-day SMA	203.3
50-day SMA vs 200-day SMA	50over200
5Y total return	58.08%
All Time High	214.3
All Time High Change	-11.13%
All Time High Date	2026-04-02
All Time Low	30.51
All Time Low Change	524.11%
All Time Low Date	1998-10-02
ATR	4
Ch YTD	7.73
High	191.4
High52	214.3
High52 Date	2026-04-02
High52ch	-11.13%
Low	188.8
Low52	129
Low52 Date	2025-07-01
Low52ch	47.63%
Ma50ch	-6.31%
Price vs 200-day SMA	7.33%
RSI	38.16
RSI Monthly	62.24
RSI Weekly	52.09
Sharpe ratio	1.76x
Sortino ratio	3.06
Total Return	2.07%
Tr YTD	8.3
Tr15y	548.25%
Tr1m	-7.73%
Tr1w	-0.71%
Tr3m	-4.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 23.1B
Operating Income Growth	17.5
Operating Income Growth Q	4.05
Operating Income Growth3 Y	6.76
Operating Income Growth5 Y	4.61
Operating margin	27.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,403,389,742%
Net Borrowing	1,526,331,600
Shares Insiders	0.04%
Shares Institutions	75.42%
Shares Qo Q	0.25%
Shares Yo Y	0.29%
Short Ratio	2.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 14.3B
Average Volume	335x
Bv Per Share	29.28
CAPEX	EUR -4.4B
Ch10y	93.62
Ch15y	320.9
Ch1m	-7.73
Ch1w	-0.71
Ch1y	36.85
Ch20y	315
Ch3m	-5.25
Ch3y	29.55
Ch5y	37.28
Ch6m	18.12
Change	0.5%
Change From Open	-0.5
Close	189.5
Days Gap	1
Depreciation Amortization	6,558,986,070
Dollar Volume	15,425.6
Earnings Date	2026-04-14
EBIT	EUR 23.1B
EBITDA	EUR 29.8B
EPS	EUR 7.5
F Score	5
FCF	EUR 15.4B
FCF EV Yield	3.21x
Financing CF	-13,394,108,000
Fiscal Year End	December
Founded	1,886
Goodwill	41,175,338,796
Graham Number	71.59492
Graham Upside	-62.41
Income Tax	EUR 3.4B
Investing CF	-21,119,308,000
Is Primary Listing	0
Last Earnings Date	2026-04-14
Last Report Date	2026-03-29
Last Split Date	2001-06-13
Last Split Type	Forward
Lynch Fair Value	EUR 52.54
Lynch Upside	-72.41
Ma150	186.6
Ma150ch	2.04%
Ma20	195.8
Ma20ch	-2.72%
Net CF	-14,570,248,000
Next Earnings Date	2026-07-14
Open	191.4
P FCF Ratio	29.32
P OCF Ratio	22.8
Payment Date	2026-03-10
Position In Range	62.79
Ppne	19,732,075,740
Price Date	2026-05-08
Price EBITDA	EUR 15.19
Relative Volume	0.24x
Revenue	83,642,216,000x
SBC By Revenue	1.42x
Share Based Comp	1,185,688,000
Tax By Revenue	4.05x
Tax Rate	15.64%
Tr20y	640.8%
Tr6m	19.51%
Volume	81
Z Score	4.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/JNJ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$4.49 annual per share

Payout ratio

+59.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.3%

14 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-02-24

Performance

FRA/JNJ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/JNJ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.4%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/JNJ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.2

Neutral momentum band

Price vs 200-day MA

+7.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/JNJ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/JNJ stock rating?

fra/JNJ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/JNJ analysis?

The full report lives at /stocks/fra/JNJ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/JNJ?

The latest report frames fra/JNJ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/JNJ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.